β¨ Health Appointments and Medicine Approvals
4428 NEW ZEALAND GAZETTE, No. 183 10 DECEMBER 2009
This appointment will take effect on 1 January 2010 and will end on 5 December 2010.
Dated at Wellington this 23rd day of November 2009.
HON TONY RYALL, Minister of Health.
go10064
Health Practitioners Competence Assurance Act 2003
Appointments to the Health Practitioners Disciplinary Tribunal
Pursuant to section 87 of the Health Practitioners Competence Assurance Act 2003, I appoint
Jennifer Mace
Richard Savill
as members of the Health Practitioners Disciplinary Tribunal for five-year terms of office commencing on the date of this notification.
Dated at Wellington this 8th day of December 2009.
HON TONY RYALL, Minister of Health.
go10065
Hutt Valley District Health Board Appointment
I have appointed
Deborah (Debbie) Chin
as a member of the Hutt District Health Board.
This appointment will take effect on 23 November 2009 and will end on 5 December 2010.
Dated at Wellington this 23rd day of November 2009.
HON TONY RYALL, Minister of Health.
go10196
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Cancidas
Active Ingredient: Caspofungin acetate 60.6mg equivalent to 50mg caspofungin anhydrous free base
Dosage Form: Powder for infusion
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck & Co Inc, West Point, Pennsylvania, United States of America
OSO BioPharmaceuticals Manufacturing, LLC, Albuquerque, New Mexico, United States of America
Product: Cancidas
Active Ingredient: Caspofungin acetate 83.9mg equivalent to 70mg caspofungin anhydrous free base
Dosage Form: Powder for infusion
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck & Co Inc, West Point, Pennsylvania, United States of America
OSO BioPharmaceuticals Manufacturing, LLC, Albuquerque, New Mexico, United States of America
Product: Seroquel XR
Active Ingredient: Quetiapine fumarate 57.56mg equivalent quetiapine free base 50mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: AstraZeneca Pharmaceuticals LP, Newark, Delaware, United States of America
AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom
Product: Seroquel XR
Active Ingredient: Quetiapine fumarate 230.26mg equivalent to quetiapine free base 200mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: AstraZeneca Pharmaceuticals LP, Newark, Delaware, United States of America
AstraZeneca UK Ltd, Macclesfield, Cheshire, United Kingdom
Product: Seroquel XR
Active Ingredient: Quetiapine fumarate 345.38mg equivalent to quetiapine free base 300mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: AstraZeneca Pharmaceuticals LP, Newark, Delaware, United States of America
AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom
Next Page →
β¨ LLM interpretation of page content
π₯ Health Practitioners Disciplinary Tribunal Appointments
π₯ Health & Social Welfare8 December 2009
Appointments, Health Practitioners Disciplinary Tribunal, Wellington
- Jennifer Mace, Appointed to Health Practitioners Disciplinary Tribunal
- Richard Savill, Appointed to Health Practitioners Disciplinary Tribunal
- HON TONY RYALL, Minister of Health
π₯ Hutt Valley District Health Board Appointment
π₯ Health & Social Welfare23 November 2009
Appointment, Hutt Valley District Health Board, Wellington
- Deborah (Debbie) Chin, Appointed to Hutt Valley District Health Board
- HON TONY RYALL, Minister of Health
π₯ Consent to Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Approval, Distribution, Cancidas, Seroquel XR
- HON TONY RYALL, Minister of Health
NZ Gazette 2009, No 183